Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biotech

News DISCO Pharmaceuticals signs license deal with Amgen Biotech deal. Surfaceome technology convinces pharmaceutical giant. DISCO licenses novel cancer target to Amgen.

Marc Nemitz 07.01.2026

News 5 million euros seed for Amplifold DNA origami for rapid tests. Amplifold increases the sensitivity of LFAs by up to 100-fold. The seed financing has now been completed.

Marc Nemitz 10.12.2025

News That's fat - € 7.3 million Series A for Melt&Marble EIC Fund, Beiersdorf and Valio invest. Melt&Marble starts the commercialization of its fermentation-based high-performance fats with € 7.3 million Series A.

Marc Nemitz 08.12.2025

News Qorium secures 22 million euros to bring cultivated leather to the mass market Investors focus on sustainable materials. The biotech from Maastricht wants to revolutionize the leather industry.

Marc Nemitz 11.11.2025

News Tubulis closes Series C round for 344 million euros Munich-based biotech Tubulis accelerates ADC development following strong clinical data. € Total Series C financing increases to € 344 million.

Marc Nemitz 04.11.2025

News 4.7 million euros pre-series A for smartbax Medical innovation made in Oberschleissheim. smartbax aims to get to the root of the global resistance problem with novel mechanisms of action.

Marc Nemitz 22.10.2025

News Series-C over 308 million euros for Tubulis Europe in the biotech spotlight. With the largest Series C round of a European biotech company to date, Tubulis is driving clinical trials for TUB-040 and strengthening the European biotech landscape.

Marc Nemitz 15.10.2025

News Mevaldi secures financing Mevaldi scales bio-based building block for polymers and receives funding from HTGF & ICIG Ventures.

Marc Nemitz 10.09.2025

News PROVIREX and LIV receive 1.7 million euros in funding for gene therapy platform Gene therapy against underestimated retroviruses. PROVIREX and the Leibniz Institute of Virology receive 1.7 million euros in funding for the development of a modular gene therapy platform against HTLV-1.

Marc Nemitz 30.07.2025

News Pila Pharma raises capital for new oral obesity therapy Pila Pharma receives EUR 1.8 million for new oral obesity therapy with TRPV1 inhibitor. Dorte X. Gram develops new tablet solution against obesity.

Marc Nemitz 14.07.2025

1
2
3
4